Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Capital Expenditures (2023 - 2025)

Historic Capital Expenditures for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $7.7 million.

  • Nuvation Bio's Capital Expenditures rose 513445.95% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 414840.43%. This contributed to the annual value of $162000.0 for FY2024, which is 13478.26% up from last year.
  • According to the latest figures from Q3 2025, Nuvation Bio's Capital Expenditures is $7.7 million, which was up 513445.95% from $181000.0 recorded in Q2 2025.
  • Over the past 5 years, Nuvation Bio's Capital Expenditures peaked at $7.7 million during Q3 2025, and registered a low of -$13000.0 during Q4 2024.
  • Over the past 3 years, Nuvation Bio's median Capital Expenditures value was $24500.0 (recorded in 2023), while the average stood at $823100.0.
  • In the last 5 years, Nuvation Bio's Capital Expenditures crashed by 20000.0% in 2024 and then surged by 513445.95% in 2025.
  • Quarter analysis of 3 years shows Nuvation Bio's Capital Expenditures stood at $13000.0 in 2023, then tumbled by 200.0% to -$13000.0 in 2024, then skyrocketed by 59692.31% to $7.7 million in 2025.
  • Its Capital Expenditures stands at $7.7 million for Q3 2025, versus $181000.0 for Q2 2025 and $72000.0 for Q1 2025.